基本信息
浏览量:340
职业迁徙
个人简介
Terho Lehtimäki MD, PhD is currently a professor of Clinical Chemistry and Chief Physician of the Department of Clinical Chemistry, University of Tampere, School of Medicine and Fimlab Laboratories (Ltd), Pirkanmaa Hospital District, Finland which is the second largest clinical laboratory in Finland. His research interests are focused on cardiovascular disease risk factors, atherosclerosis biomarkers, vascular and cell biology and functional genetics of diseases. Terho Lehtimäki has over 650 publications from the field including articles in all world top journals, e.g., Science, Lancet, Nature, Nature Genetics, JAMA and Circulation. Tampere is the coordinating partner in an EU Collaborative Project on Inflammation and Vascular Wall Remodeling (AtheroRemo) and partner in several other collaborative efforts within the European Union and in the US and Canada. In addition Terho Lehtimäki is the responsible investigator of the genetic section of The Cardiovascular Risk In Young Finns study (YFS) and The Finnish Cardiovascular Study (FINCAVAS) and the leader of The Tampere Vascular Study (TVS) focusing on the use of “OMICS” techniques in the research of atherosclerosis and functional genetics.
研究兴趣
论文共 441 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
arxiv(2023)
Frontiers in cardiovascular medicine (2023): 1125151
引用0浏览0WOS引用
0
0
Journal of the American Heart Associationno. 14 (2023)
引用0浏览0WOS引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn